Summary Integrating emerging mechanistic and clinical observations, this review synthesizes current evidence from a metabolic flux perspective
We also review the studies on protein from different sources that has inhibitory effects on dipeptidyl peptidase-4 (DPP4), the enzyme responsible for GLP-1 inactivation, with particular emphasis on specific sources and treatments, and the gaps there still are in knowledge
The FDA has issued a warning last month about compounded versions of semaglutide
It discusses what the Ozempic lawsuit is about, who can file a claim, how to file one, possible types of compensation, and the types of injuries Ozempic patients are experiencing
Bring a friend along for the ride
Moderators of varenicline treatment effects in a double-blind, placebo-controlled trial for alcohol dependence: an exploratory Analysis